Cox Bryan F. sold $1K of TLSI
Cox Bryan F. (Chief of Research) sold 296 shares of TriSalus Life Sciences, Inc. (TLSI) at $4.39 on 2026-10-05.
How this was made
The 30-second read
Why it matters
The transaction is modest and unlikely to move the stock significantly.
Market read
Small insider sale with limited trading relevance.
What to watch
Potential upcoming corporate actions or clinical trial news not disclosed in this filing.
Background
Form 4 filing from SEC EDGAR reporting an insider transaction.
Ticker impact
Chief of Research Cox Bryan F. sold 296 shares of TLSI at $4.39 each, total $1,299.44, reducing his holdings to 162,805 shares.
likely modest pressure as the market prices in the insider sale.
The sale is small relative to float and typical insider activity, so impact is limited.
Market effects
Minimal effect on biotech sector; typical insider transactions.
No regional impact beyond the company's share price.
Not globally relevant.
Counterpoint
The sale could be interpreted as a lack of confidence, but size is too small to signal material concern.
Key entities
- CompanyTriSalus Life Sciences, Inc.
Biotech firm listed on Nasdaq under ticker TLSI.
- IndividualCox Bryan F.
Chief of Research at TLSI, reporting an insider sale.